Healthy Inc > Blog > Cefoperazone manufacturer India
Posted on:

What is cefoperazone-sulbactam injection used for?

Pharmaceutical Product Monograph: Cefoperazone & Sulbactam Sodium Injection

In the pharmaceutical industry, the combination of Cefoperazone and Sulbactam is a potent, synergistic Beta-lactam/Beta-lactamase Inhibitor (BLI). As a pharmacist and manufacturer at your WHO-GMP facility in Mumbai, I view this formulation as a “Resistant-Strain Specialist”—it is technically designed to combat serious infections where bacteria produce enzymes that would otherwise destroy standard cephalosporins.

This combination is a cornerstone of ICU and Critical Care medicine, particularly in the Asia-Pacific and African markets, due to its superior activity against Acinetobacter baumannii and Pseudomonas aeruginosa.

Therapeutic Profile: Primary Indications

Cefoperazone-Sulbactam is indicated for the treatment of severe, complicated infections caused by susceptible organisms, often where multi-drug resistance (MDR) is suspected.

IndicationClinical ContextTechnical Rationale
Intra-abdominal InfectionsPeritonitis / CholangitisDrug of Choice. High biliary excretion makes it ideal for gallbladder and gut infections.
Respiratory TractVAP / Nosocomial PneumoniaTargets “Hospital-Acquired” bacteria that are often resistant to 1st/2nd Gen antibiotics.
Urinary Tract (UTI)Pyelonephritis / UrosepsisEffective against ESBL-producing E. coli and other complicated pathogens.
SepticemiaBloodstream InfectionUsed as an empirical heavy-duty intravenous treatment for systemic sepsis.
GynecologicalPID / EndometritisProvides broad coverage for mixed aerobic and anaerobic pelvic infections.

Mechanism: The “Synergistic Blockade”

This combination works through a dual-action biochemical strategy to bypass bacterial resistance:

Cefoperazone (The Executioner): A 3rd-generation cephalosporin that binds to Penicillin-Binding Proteins (PBPs). It inhibits bacterial cell wall synthesis, leading to osmotic lysis and cell death.

Sulbactam (The Bodyguard): A $\beta$-lactamase inhibitor. Many resistant bacteria produce enzymes (beta-lactamases) that “snip” the cephalosporin ring. Sulbactam binds irreversibly to these enzymes, “neutralizing” them so that Cefoperazone can do its job.

The Pharmacist’s “Technical Warning”

  • The “Disulfiram” Reaction: As a pharmacist, I must emphasize: Alcohol must be avoided during and for 3 days after treatment. Cefoperazone can interfere with alcohol metabolism, causing severe nausea, racing heart, and vomiting.

  • Coagulation Monitoring: The N-methylthiotetrazole side chain in Cefoperazone can interfere with Vitamin K metabolism. Patients on long-term therapy or anticoagulants (Warfarin) should have their Prothrombin Time (PT/INR) monitored.

  • The “Acinetobacter” Advantage: Technically, Sulbactam has its own intrinsic activity against Acinetobacter species, making this combination more effective against this specific “superbug” than Ceftriaxone or Ceftazidime.

  • Renal/Hepatic Balance: Because Cefoperazone is primarily excreted in the bile, it is generally safer for patients with kidney failure, though dose adjustments may be needed if both liver and kidney functions are impaired.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Fixed-Dose Ratio” USP: We manufacture this in 1:1 and 2:1 ratios (e.g., 1g:1g or 1g:0.5g). On your digital marketplace, highlight the 2:1 ratio (1.5g total) as the most common international standard for surgical prophylaxis and critical care.

  • Aseptic Powder Filling: Both ingredients are highly sensitive to moisture. Your WHO-GMP moisture-controlled “Dry Powder” suite ensures the stability of the $\beta$-lactam ring, providing a 24-month shelf life.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Cefoperazone-Sulbactam (1.5g and 3g) to support your registration in international B2B hospital supply contracts.

Cefoperazone & Sulbactam 2Gm Injection

Posted on:

What is cefoperazone-sulbactam injection used for?

Pharmaceutical Product Monograph: Cefoperazone & Sulbactam Sodium Injection

In the pharmaceutical industry, the combination of Cefoperazone and Sulbactam is a potent, synergistic Beta-lactam/Beta-lactamase Inhibitor (BLI). As a pharmacist and manufacturer at your WHO-GMP facility in Mumbai, I view this formulation as a “Resistant-Strain Specialist”—it is technically designed to combat serious infections where bacteria produce enzymes that would otherwise destroy standard cephalosporins.

This combination is a cornerstone of ICU and Critical Care medicine, particularly in the Asia-Pacific and African markets, due to its superior activity against Acinetobacter baumannii and Pseudomonas aeruginosa.

Therapeutic Profile: Primary Indications

Cefoperazone-Sulbactam is indicated for the treatment of severe, complicated infections caused by susceptible organisms, often where multi-drug resistance (MDR) is suspected.

IndicationClinical ContextTechnical Rationale
Intra-abdominal InfectionsPeritonitis / CholangitisDrug of Choice. High biliary excretion makes it ideal for gallbladder and gut infections.
Respiratory TractVAP / Nosocomial PneumoniaTargets “Hospital-Acquired” bacteria that are often resistant to 1st/2nd Gen antibiotics.
Urinary Tract (UTI)Pyelonephritis / UrosepsisEffective against ESBL-producing E. coli and other complicated pathogens.
SepticemiaBloodstream InfectionUsed as an empirical heavy-duty intravenous treatment for systemic sepsis.
GynecologicalPID / EndometritisProvides broad coverage for mixed aerobic and anaerobic pelvic infections.

Mechanism: The “Synergistic Blockade”

This combination works through a dual-action biochemical strategy to bypass bacterial resistance:

Cefoperazone (The Executioner): A 3rd-generation cephalosporin that binds to Penicillin-Binding Proteins (PBPs). It inhibits bacterial cell wall synthesis, leading to osmotic lysis and cell death.

Sulbactam (The Bodyguard): A $\beta$-lactamase inhibitor. Many resistant bacteria produce enzymes (beta-lactamases) that “snip” the cephalosporin ring. Sulbactam binds irreversibly to these enzymes, “neutralizing” them so that Cefoperazone can do its job.

Shutterstock
Explore

The Pharmacist’s “Technical Warning”

  • The “Disulfiram” Reaction: As a pharmacist, I must emphasize: Alcohol must be avoided during and for 3 days after treatment. Cefoperazone can interfere with alcohol metabolism, causing severe nausea, racing heart, and vomiting.

  • Coagulation Monitoring: The N-methylthiotetrazole side chain in Cefoperazone can interfere with Vitamin K metabolism. Patients on long-term therapy or anticoagulants (Warfarin) should have their Prothrombin Time (PT/INR) monitored.

  • The “Acinetobacter” Advantage: Technically, Sulbactam has its own intrinsic activity against Acinetobacter species, making this combination more effective against this specific “superbug” than Ceftriaxone or Ceftazidime.

  • Renal/Hepatic Balance: Because Cefoperazone is primarily excreted in the bile, it is generally safer for patients with kidney failure, though dose adjustments may be needed if both liver and kidney functions are impaired.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Fixed-Dose Ratio” USP: We manufacture this in 1:1 and 2:1 ratios (e.g., 1g:1g or 1g:0.5g). On your digital marketplace, highlight the 2:1 ratio (1.5g total) as the most common international standard for surgical prophylaxis and critical care.

  • Aseptic Powder Filling: Both ingredients are highly sensitive to moisture. Your WHO-GMP moisture-controlled “Dry Powder” suite ensures the stability of the $\beta$-lactam ring, providing a 24-month shelf life.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Cefoperazone-Sulbactam (1.5g and 3g) to support your registration in international B2B hospital supply contracts.

Home

Posted on:

What is cefoperazone injection used for?

Pharmaceutical Product Monograph: Cefoperazone Sodium Injection (500 mg, 1 g)

In the pharmaceutical industry, Cefoperazone is a semi-synthetic, broad-spectrum Third-Generation Cephalosporin antibiotic. As a pharmacist and manufacturer at your WHO-GMP facility in Mumbai, I view this molecule as a “Biliary Specialist”—it is technically unique among cephalosporins because it is primarily excreted through the bile rather than the kidneys, making it a critical tool for patients with renal impairment.

Cefoperazone is a potent $\beta$-lactam antibiotic specifically designed to target difficult-to-treat Gram-negative bacteria, including Pseudomonas aeruginosa.

Therapeutic Profile: Primary Indications

Cefoperazone injection is indicated for the treatment of severe infections caused by susceptible microorganisms, particularly in the respiratory and abdominal tracts.

IndicationClinical ContextTechnical Rationale
Biliary Tract InfectionsCholecystitis / CholangitisDrug of Choice. Achieves high therapeutic concentrations in the bile and gallbladder.
Respiratory InfectionsSevere PneumoniaEffective against a wide range of pathogens, including those resistant to earlier penicillins.
PeritonitisIntra-abdominal SepsisOften used in combination with Sulbactam to cover anaerobic bacteria and resistant strains.
SepticemiaBloodstream InfectionUsed as an empirical intravenous treatment for suspected bacterial sepsis.
Skin & Soft TissueDiabetic Foot / UlcersTargets Pseudomonas and other Gram-negative bacilli in deep tissue infections.

Mechanism: Inhibition of Bacterial Cell Wall Synthesis

Cefoperazone works by disrupting the structural integrity of the bacterial cell wall during the active growth phase:

PBP Binding: The molecule binds to specific Penicillin-Binding Proteins (PBPs) located on the inner membrane of the bacterial cell.

Peptidoglycan Blockade: It inhibits the final “transpeptidation” step of cell wall synthesis, preventing the cross-linking of peptidoglycan strands.

Osmotic Lysis: The weakened cell wall cannot withstand internal pressure. Water enters the cell, causing it to swell and burst (Lysis), resulting in bacterial death.

The Pharmacist’s “Technical Warning”

  • The “Disulfiram” Reaction: As a pharmacist, I must warn: Patients must avoid alcohol during and for 72 hours after treatment. Cefoperazone contains a N-methylthiotetrazole (MTT) side chain that can cause severe nausea, vomiting, and tachycardia if alcohol is consumed.

  • Hypoprothrombinemia: The MTT side chain can also interfere with Vitamin K metabolism, potentially leading to increased bleeding. Patients on anticoagulants (like Warfarin) require close monitoring.

  • Biliary Sludging: Due to high biliary excretion, rare cases of “pseudolithiasis” (gallbladder sludging) can occur, which usually resolves after stopping the drug.

  • Renal Safety: Unlike Ceftriaxone or Ceftazidime, Cefoperazone does not technically require dose adjustment in patients with Renal Failure, making it safer for geriatric or dialysis patients.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Sulbactam Synergy” USP: On your digital marketplace, highlight your Cefoperazone + Sulbactam (1:1 or 2:1) combinations. Sulbactam protects Cefoperazone from $\beta$-lactamase enzymes, making the combination a market leader in ICU and critical care settings.

  • Stability for Export: Cefoperazone Sodium is light-sensitive. Your Amber USP Type I glass vials and nitrogen-blanketed filling process ensure a 24-month shelf life in the heat of Zone IVb climates.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Cefoperazone 1g and combination vials to support your registration in international B2B tenders for hospital and surgical supplies.

Home

Posted on:

What is cefoperazone used to treat?

Pharmaceutical Product Monograph: Cefoperazone Sodium (1 g)

In the pharmaceutical industry, Cefoperazone is a parenteral, semi-synthetic Third-Generation Cephalosporin antibiotic. As a pharmacist and manufacturer, I view this molecule as the “Biliary Specialist”—it is technically unique because, unlike most other cephalosporins, it is primarily excreted through the bile (liver) rather than the kidneys. This makes it an essential tool for treating infections in patients with renal failure.

At your WHO-GMP facility in Mumbai, Cefoperazone is a high-volume SKU, often manufactured in a 1:1 or 2:1 ratio with Sulbactam to overcome bacterial resistance.

Therapeutic Profile: Primary Indications

Cefoperazone is indicated for a broad range of severe infections, with a particular focus on the gastrointestinal and biliary systems.

IndicationClinical ContextTechnical Rationale
Biliary Tract InfectionsCholecystitis / CholangitisGold Standard: Reaches concentrations in the bile 8–10 times higher than in the blood.
PeritonitisIntra-abdominal SepsisEffective against a wide array of aerobic and anaerobic organisms found in the gut.
Pseudomonal InfectionsHAP / VAPOne of the few 3rd-gen cephalosporins with significant activity against Pseudomonas aeruginosa.
Respiratory TractSevere PneumoniaUsed in hospitalized patients with multi-drug resistant (MDR) lung infections.
SepticemiaBloodstream InfectionUsed as empirical therapy for patients showing signs of systemic shock.

Mechanism: Cell Wall Transpeptidase Inhibition

Cefoperazone works by sabotaging the structural integrity of the bacterial cell wall during the growth phase:

PBP Affinity: The drug binds to Penicillin-Binding Proteins (PBPs) on the inner bacterial membrane.

Peptidoglycan Blockade: It inhibits the final cross-linking step (transpeptidation) of cell wall synthesis.

Bacterial Lysis: Technically, this creates a “weak” cell wall that cannot withstand the bacteria’s internal osmotic pressure, causing the cell to burst and die.

The Pharmacist’s “Technical Warning”

  • The “Disulfiram” Interaction: As a pharmacist, I must warn that Cefoperazone contains an MTT side chain. If a patient consumes alcohol during or up to 72 hours after treatment, they will experience severe nausea, vomiting, and tachycardia (Disulfiram-like reaction).

  • The “Vitamin K” Risk: The same MTT side chain can technically interfere with Vitamin K metabolism, leading to a risk of bleeding. High-risk patients may require Vitamin K supplements during therapy.

  • The “No Renal Adjustment” Rule: Because it is excreted via the liver, no dose reduction is technically required for patients with Kidney Failure, making it a very safe “Renal-Friendly” antibiotic.

  • Sulbactam Synergy: If you are using the Cefoperazone-Sulbactam combination, the Sulbactam technically “protects” the Cefoperazone from being eaten by bacterial enzymes (Beta-lactamases).

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Hygroscopic” USP: On your digital marketplace, highlight your Advanced Moisture-Proof Sealing. Cefoperazone Sodium is highly hygroscopic (absorbs water from the air). Your Aseptic Filling Line ensures the powder remains free-flowing and stable for a 24-month shelf life.

  • The “Cold Chain” Optionality: While stable at room temperature in many regions, for Zone IVb (Tropical) exports, we recommend storage below $25^\circ\text{C}$ to prevent “browning” of the powder.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Cefoperazone 1 g and Cefoperazone-Sulbactam 1.5 g / 2 g to support your registration in international B2B tenders for gastrointestinal and critical care.

Cefoperazone & Tazobactam Injection

Add to cart